NasdaqGS:TSHABiotechs
Assessing Taysha Gene Therapies (TSHA) Valuation After A Strong 57% One Month Share Price Move
Event context and recent stock move
Taysha Gene Therapies (TSHA) has recently been on investors’ radar after a sharp move in its share price over the past month, with returns of about 57% across that period.
See our latest analysis for Taysha Gene Therapies.
That recent 57.3% 1 month share price return for Taysha sits alongside a 35.6% 3 month share price gain and a very large 1 year total shareholder return. This suggests momentum has been building around the current US$6.40 price.
If you...